Prognoses, outcomes, and clinicopathological characteristics of very elderly patients with hepatocellular carcinoma who underwent hepatectomy

被引:13
|
作者
Shimada, Shingo [1 ]
Kamiyama, Toshiya [1 ]
Orimo, Tatsuya [1 ]
Nagatsu, Akihisa [1 ]
Asahi, Yoh [1 ]
Sakamoto, Yuzuru [1 ]
Kamachi, Hirofumi [1 ]
Taketomi, Akinobu [1 ]
机构
[1] Hokkaido Univ, Dept Gastroenterol Surg 1, Grad Sch Med, Kita Ku, North 15 West 7, Sapporo, Hokkaido 0608638, Japan
关键词
Elderly; Hepatectomy; Hepatocellular carcinoma; HEPATIC RESECTION; RISK-FACTORS; AGE; SURVIVAL; CANCER; DIAGNOSIS; FEATURES; DISEASE;
D O I
10.1186/s12957-020-01899-4
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives The aim was to evaluate the prognostic factors, clinicopathological characteristics, and surgical outcomes after hepatectomy in very elderly patients with hepatocellular carcinoma (HCC). Methods We analyzed 796 patients with HCC from 2000 to 2017. Patients aged 80 years or older were classified into the very elderly group (group VE;n= 49); patients younger than 80 years old and aged 65 years or older were classified into the elderly group (group E;n= 363), and patients younger than 65 years old were classified into the young group (group Y;n= 384). We investigated the prognoses, clinicopathological characteristics, and surgical outcomes after hepatectomy. Results The number of surgical procedures and outcomes, including morbidities, was not significantly different. Groups VE, E, and Y showed similar prognoses in terms of both survival and recurrence. In group VE, prothrombin activity (PA) < 80% and PIVKA-II >= 400 mAU/ml were unfavorable factors for survival, and PIVKA-II >= 400 mAU/ml and the presence of portal venous invasion (PVI), hepatic venous invasion, and fibrosis were unfavorable factors for recurrence. In group E, ChE < 180 IU/l, AFP >= 20 ng/ml, tumor size >= 10 cm, and the presence of multiple tumors, PVI, and hepatic venous invasion (HVI) were unfavorable factors for survival, and ChE < 180 IU/l, tumor size >= 10 cm, and the presence of multiple tumors, PVI, and HVI were unfavorable factors for recurrence. In group Y, AFP >= 20 ng/ml, the presence of multiple tumors, poor differentiation, PVI, HVI, and blood loss >= 400 ml were unfavorable factors for survival, and PA < 80%, albumin < 3.5 g/dl, AFP >= 20 ng/ml, tumor size >= 10 cm, and the presence of multiple tumors, poor differentiation, and PVI were unfavorable factors for recurrence. Conclusions Tumor factors might have limited influence on the prognosis of very elderly patients, and liver function reserve might be important for the long-term survival of very elderly patients. Hepatectomy can be performed safely, even in very elderly patients. Hepatectomy should not be avoided in very elderly patients with HCC if patients have a good general status because these patients have the same prognoses as nonelderly individuals.
引用
收藏
页数:11
相关论文
共 50 条
  • [21] Safety of hepatectomy for elderly patients with hepatocellular carcinoma
    Koichi Oishi
    Toshiyuki Itamoto
    Toshihiko Kohashi
    Yasuhiro Matsugu
    Hideki Nakahara
    Mikiya Kitamoto
    World Journal of Gastroenterology, 2014, (41) : 15028 - 15036
  • [22] Major hepatectomy is safe for hepatocellular carcinoma in elderly patients with cirrhosis
    Wang, Wan-li
    Zhu, Ying
    Cheng, Ji-wen
    Li, Mu-xing
    Xia, Jian-min
    Hao, Jie
    Yu, Liang
    Lv, Yi
    Wu, Zheng
    Wang, Bo
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (04) : 444 - 451
  • [23] Outcomes of hepatectomy for hepatocellular carcinoma in elderly patients: a single-center study
    Pham, Anh The
    Truong, Cuong Manh
    Trinh, Phuong Huy
    Vu, Toan Quang
    Pham, Hoan My
    INTERNATIONAL JOURNAL OF SURGERY OPEN, 2024, 62 (06) : 797 - 801
  • [24] Laparoscopic versus open hepatectomy for elderly patients with hepatocellular carcinoma
    Chen, Yajun
    Yu, Lili
    Quan, Changyin
    JOURNAL OF BUON, 2020, 25 (03): : 1404 - 1412
  • [25] Evaluation of New Prognostic Staging Systems (SLiDe score) for Hepatocellular Carcinoma Patients who Underwent Hepatectomy
    Nanashima, Atsushi
    Omagari, Katsuhisa
    Sumida, Yorihisa
    Abo, Takafumi
    Fukuoka, Hidetoshi
    Takeshita, Hiroaki
    Hidaka, Shigekazu
    Tanaka, Kenji
    Sawai, Terumitsu
    Yasutake, Toru
    Nagayasu, Takeshi
    Mizuta, Youhei
    Ohba, Kazuo
    Ohnita, Ken
    Kadokawa, Yoshiko
    HEPATO-GASTROENTEROLOGY, 2009, 56 (93) : 1137 - 1140
  • [26] Clinicopathological characteristics and prognostic factors in young patients after hepatectomy for hepatocellular carcinoma
    Shingo Shimada
    Toshiya Kamiyama
    Hideki Yokoo
    Kenji Wakayama
    Yosuke Tsuruga
    Tatsuhiko Kakisaka
    Hirofumi Kamachi
    Akinobu Taketomi
    World Journal of Surgical Oncology, 11
  • [27] The Outcomes of Elderly Patients With Hepatocellular Carcinoma Treated With Transarterial Chemoembolization
    Yau, Thomas
    Yao, Tzy Jyun
    Chan, Pierre
    Epstein, Richard John
    Ng, Kelvin K.
    Chok, Siu Ho
    Cheung, Tan Teo
    Fan, Sheung Tat
    Poon, Ronnie Tung Ping
    CANCER, 2009, 115 (23) : 5507 - 5515
  • [28] Clinical characteristics of hepatocellular carcinoma in elderly patients
    Honda, Takuya
    Miyaaki, Hisamitsu
    Ichikawa, Tatsuki
    Taura, Naota
    Miuma, Satoshi
    Shibata, Hidetaka
    Isomoto, Hajime
    Takeshima, Fuminao
    Nakao, Kazuhiko
    ONCOLOGY LETTERS, 2011, 2 (05) : 851 - 854
  • [29] Clinical significances of several fibrotic markers for prognosis in hepatocellular carcinoma patients who underwent hepatectomy
    Nanashima, Atsushi
    Hiyoshi, Masahide
    Imamura, Naoya
    Hamada, Takeomi
    Tsuchimochi, Yuki
    Shimizu, Ikko
    Ochiai, Takahiro
    Nagata, Kenji
    Hasuike, Satoru
    Nakamura, Kenichi
    Iwakiri, Hisayoshi
    Kawakami, Hiroshi
    TRANSLATIONAL CANCER RESEARCH, 2024, 13 (05) : 2332 - 2345
  • [30] Hepatocellular carcinoma in elderly: Clinical characteristics, treatments and outcomes compared with younger adults
    Guo, Hui
    Wu, Tao
    Lu, Qiang
    Dong, Jian
    Ren, Yi-Fan
    Nan, Ke-Jun
    Lv, Yi
    Zhang, Xu-Feng
    PLOS ONE, 2017, 12 (09):